New Market Study Published: Dacomitinib (Non-Small Cell Lung Cancer …
SBWire (press release)
Boston, MA — (SBWIRE) — 10/04/2013 — Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer in men and women. Historically, the treatment paradigm has centered around chemotherapy. However …
Lung Cancer in 2013: Where Are We?
View full post on lung cancer – Google News